| abstract |
Anti-B7-H3 antibodies, antigen-binding fragments thereof, and pharmaceutical compositions comprising the antibodies or antigen-binding fragments are provided. Also provided is the use of the antibody or antigen-binding fragment in the preparation of a medicament for the treatment of a B7-H3-mediated disease or condition. The antibody can be a murine antibody, a chimeric antibody, a humanized antibody, or a human antibody. The pharmaceutical composition can be used to treat cancer. |